Darotropium bromide

TargetMol
Product Code: TAR-T31207
Supplier: TargetMol
CodeSizePrice
TAR-T31207-1mg1mg£175.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-5mg5mg£328.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-10mg10mg£456.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-25mg25mg£702.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-50mg50mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-100mg100mg£1,259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31207-500mg500mg£2,448.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Darotropium bromide(GSK233705, GSK233705B) is an inhaled long-acting muscarinic antagonist under development for the treatment of chronic obstructive pulmonary disease (COPD).GSK233705 showed bronchiectasis activity and was well tolerated.
CAS:
850607-58-8
Formula:
C24H29BrN2
Molecular Weight:
425.414
Pathway:
Neuroscience
Purity:
0.98
SMILES:
[Br-].[H][C@@]12CC[C@]([H])(CC(CC(C#N)(c3ccccc3)c3ccccc3)C1)[N+]2(C)C
Target:
AChR

References

1. Beier J, van Noord J, Deans A, Brooks J, Maden C, Baggen S, Mehta R, Cahn A. Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD patients. Int J Chron Obstruct Pulmon Dis. 2012;7:153-64. doi: 10.2147/COPD.S26100. Epub 2012 Mar 5. PubMed PMID: 22419863; PubMed Central PMCID: PMC3299545. 2. Bateman E, Feldman G, Kilbride S, Brooks J, Mehta R, Harris S, Maden C, Crater G. Efficacy and safety of the long-acting muscarinic antagonist GSK233705 delivered once daily in patients with COPD. Clin Respir J. 2012 Oct;6(4):248-57. doi: 10.1111/j.1752-699X.2011.00278.x. Epub 2012 Feb 13. PubMed PMID: 22329914. 3. Cazzola M, Matera MG. Novel long-acting bronchodilators for COPD and asthma. Br J Pharmacol. 2008 Oct;155(3):291-9. doi: 10.1038/bjp.2008.284. Epub 2008 Jul 7. Review. PubMed PMID: 18604231; PubMed Central PMCID: PMC2567883.